Combined medicine for preventing and treating tumors
A drug and tumor technology, applied in the field of medicine, can solve the problems of chemotherapeutic drug resistance, lower drug efficacy, and unclear right and wrong, and achieve the effects of expanding the applicable population, improving curative effect, and less toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Example Embodiment
[0027] Example 1: Study on anti-S180 tumor effect of cucurbitacin B (CuB) and coenzyme Q10 (Q10)
[0028] Experimental program:
[0029] Take Kunming mice, weighing 18-22 grams, male, inoculate S180 tumor in the armpit of the right forelimb, and wait until the tumor mass grows to be larger than 50 mm 2 At the time, they were randomly divided into 3 groups, each with 10 animals, and each group was given intragastric administration separately. The scheme is as follows:
[0030] Dosage: CuB: B( 5 mg / kg)
[0031] Q10: Q (50 mg / kg)
[0032] Mode of administration: CuB emulsion, B+Q composite emulsion
[0033] Control group: normal saline group
[0034] Experimental group: CuB group, CuB+Q10 group
[0035] The administration was continued for 14 days. Within 24 hours after the last administration, the animals were sacrificed and the tumors were weighed to calculate the tumor inhibition rate.
[0036] Results: The tumor inhibition rates of CuB group and CuB+Q10 group were 48.
Example Embodiment
[0038] Example 2: Study on anti-S180 tumor effect of cucurbitacin B (CuB) and taurine (T)
[0039] Experimental program:
[0040] Take Kunming mice, weighing 18-22 grams, male, inoculate S180 tumor under the armpit of the right forelimb, and wait until the tumor mass grows to more than 50 mm 2 At the time, they were randomly divided into 3 groups, 10 animals in each group, and each group was given intragastric administration separately. The scheme is as follows:
[0041] Dosage: CuB: 5 mg / kg
[0042] T: 300 mg / kg
[0043] Administration method: CuB emulsion, CuB+T composite emulsion
[0044] Control group: normal saline group
[0045] Experimental group: CuB emulsion group, CuB+T composite emulsion group
[0046] The administration was continued for 14 days. Within 24 hours after the last administration, the animals were sacrificed and the tumors were weighed to calculate the tumor inhibition rate.
[0047] Results: The tumor inhibition rates of CuB emulsion g
Example Embodiment
[0049] Example 3: Study on anti-H22 tumor effect of cucurbitacin B (CuB) and coenzyme Q10 (Q10)
[0050] Experimental program:
[0051] Take Kunming mice, weighing 18-22 grams, male, inoculate H22 tumor in the armpit of the right forelimb, and wait until the tumor mass grows to be larger than 50 mm 2 At the time, they were randomly divided into 3 groups, 10 animals in each group, and each group was given intragastric administration separately. The scheme is as follows:
[0052] Dosage: CuB: B( 5 mg / kg)
[0053] Q10: Q (50 mg / kg)
[0054] Mode of administration: CuB emulsion, B+Q composite emulsion
[0055] Control group: normal saline group
[0056] Experimental group: CuB group, CuB+Q10 group
[0057] The administration was continued for 14 days. Within 24 hours after the last administration, the animals were sacrificed and the tumors were weighed to calculate the tumor inhibition rate.
[0058] Results: The tumor inhibition rates of CuB group and CuB+Q10 group w
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap